1. Home
  2. DOX vs RGEN Comparison

DOX vs RGEN Comparison

Compare DOX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amdocs Limited

DOX

Amdocs Limited

HOLD

Current Price

$66.09

Market Cap

7.2B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$114.18

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOX
RGEN
Founded
1982
1981
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.1B
IPO Year
1998
1995

Fundamental Metrics

Financial Performance
Metric
DOX
RGEN
Price
$66.09
$114.18
Analyst Decision
Strong Buy
Buy
Analyst Count
4
11
Target Price
$92.33
$173.09
AVG Volume (30 Days)
1.4M
819.7K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
3.40%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
$4.46
$14.11
Revenue Next Year
$3.72
$14.71
P/E Ratio
$13.65
$132.19
Revenue Growth
N/A
35.10
52 Week Low
$65.74
$102.97
52 Week High
$94.61
$175.77

Technical Indicators

Market Signals
Indicator
DOX
RGEN
Relative Strength Index (RSI) 33.69 28.92
Support Level N/A $113.07
Resistance Level $70.61 $132.51
Average True Range (ATR) 1.92 6.42
MACD 0.17 -0.57
Stochastic Oscillator 13.39 6.23

Price Performance

Historical Comparison
DOX
RGEN

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: